These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2592536)

  • 1. Acinetobacter baumannii serotyping for delineation of outbreaks of nosocomial cross-infection.
    Traub WH
    J Clin Microbiol; 1989 Dec; 27(12):2713-6. PubMed ID: 2592536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotyping of clinical isolates of Acinetobacter: serovars of genospecies 3.
    Traub WH
    Zentralbl Bakteriol; 1990 May; 273(1):12-23. PubMed ID: 2363794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of polyclonal rabbit immune sera against serovars of Acinetobacter baumannii and genospecies 3 for cross-reactions with reference strains of other named/unnamed genospecies of Acinetobacter.
    Traub WH
    Zentralbl Bakteriol; 2000 Jan; 289(8):787-95. PubMed ID: 10705610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotyping of clinical isolates of Acinetobacter baumannii and genospecies 13 capable of growth at 44 degrees C: detection of four new serovars.
    Traub WH
    Zentralbl Bakteriol; 1998 Oct; 288(2):175-80. PubMed ID: 9809399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusters of nosocomial cross-infection due to Acinetobacter baumannii and genospecies 3: comparison of serotyping with macrorestriction analysis of genomic DNA with pulsed-field gel electrophoresis.
    Traub WH; Leonhard B; Bauer D
    Zentralbl Bakteriol; 1996 Jun; 284(1):115-23. PubMed ID: 8837375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotyping of clinical isolates of Acinetobacter baumannii and genospecies 3: detection of additional serovars.
    Traub WH
    Zentralbl Bakteriol; 1991 Oct; 275(4):487-94. PubMed ID: 1755922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of nosocomial cross-infections due to three Acinetobacter genospecies (Acinetobacter baumannii, genospecies 3 and genospecies 13) during a 10-Year Observation period: serotyping, macrorestriction analysis of Genomic DNA and antibiotic susceptibilities.
    Traub WH; Bauer D
    Chemotherapy; 2000; 46(4):282-92. PubMed ID: 10859434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular typing of Acinetobacter baumannii-Acinetobacter calcoaceticus complex isolates from endemic and epidemic nosocomial infections.
    Ratto P; Sordelli DO; Abeleira E; Torrero M; Catalano M
    Epidemiol Infect; 1995 Feb; 114(1):123-32. PubMed ID: 7867730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological characterization of hospital-acquired Acinetobacter baumannii isolates from a 1500-bed teaching hospital by phenotypic and genotypic methods.
    Basustaoglu AC; Kisa O; Sacilik SC; Ozyurt M; Yildiran ST
    J Hosp Infect; 2001 Mar; 47(3):246-7. PubMed ID: 11247688
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of interrepeat PCR fingerprinting to investigate an Acinetobacter baumannii outbreak in an intensive care unit.
    Debast SB; Meis JF; Melchers WJ; Hoogkamp-Korstanje JA; Voss A
    Scand J Infect Dis; 1996; 28(6):577-81. PubMed ID: 9060060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acinetobacter infection--an emerging threat to human health.
    Visca P; Seifert H; Towner KJ
    IUBMB Life; 2011 Dec; 63(12):1048-54. PubMed ID: 22006724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typing of Acinetobacter baumannii isolated from hospital-acquired respiratory infections in a tertiary care centre in southern India.
    Mathai E; Kaufmann ME; Richard VS; John G; Brahmadathan KN
    J Hosp Infect; 2001 Feb; 47(2):159-62. PubMed ID: 11170782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of use of whole-cell repetitive extragenic palindromic sequence-based PCR (REP-PCR) for typing strains belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex and application of the method to the investigation of a hospital outbreak.
    Snelling AM; Gerner-Smidt P; Hawkey PM; Heritage J; Parnell P; Porter C; Bodenham AR; Inglis T
    J Clin Microbiol; 1996 May; 34(5):1193-202. PubMed ID: 8727902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial outbreaks caused by Acinetobacter baumannii and Pseudomonas aeruginosa: Results of a systematic review.
    Wieland K; Chhatwal P; Vonberg RP
    Am J Infect Control; 2018 Jun; 46(6):643-648. PubMed ID: 29398072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrorestriction analysis (PFGE) of serologically cross-reactive serovars of Acinetobacter baumannii and genospecies 3.
    Traub WH; Leonhard B; Bauer D
    Zentralbl Bakteriol; 1997 Feb; 285(3):403-12. PubMed ID: 9084114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and molecular epidemiology of Acinetobacter baumannii strains isolated in Rabta Hospital, Tunisia.
    Ben Othman A; Zribi M; Masmoudi A; Abdellatif S; Ben Lakhal S; Fendri C
    Arch Inst Pasteur Tunis; 2007; 84(1-4):11-9. PubMed ID: 19388579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and biotyping of clinical isolates of Acinetobacter.
    Bouvet PJ; Grimont PA
    Ann Inst Pasteur Microbiol; 1987; 138(5):569-78. PubMed ID: 3440090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.
    Bou G; Cerveró G; Domínguez MA; Quereda C; Martínez-Beltrán J
    J Clin Microbiol; 2000 Sep; 38(9):3299-305. PubMed ID: 10970374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of multidrug-resistant isolates of Acinetobacter baumannii.
    Okpara AU; Maswoswe JJ
    Am J Hosp Pharm; 1994 Nov; 51(21):2671-5. PubMed ID: 7856578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents.
    Bergogne-Bérézin E
    J Hosp Infect; 1995 Jun; 30 Suppl():441-52. PubMed ID: 7560983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.